{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:31:17Z","timestamp":1793755877934,"version":"4.6.1"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005624","name":"Hannover Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001663","name":"Volkswagen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030859","name":"REBIRTH HANNOVER Forschungszentrum f\u00fcr translationale regenerative Medizin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030859","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.brainresbull.2025.111464","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T14:19:00Z","timestamp":1752589140000},"page":"111464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A holistic rat model to investigate therapeutic interventions in Parkinson\u2019s disease: viral induction of a slow-progressing motor phenotype, dopaminergic degeneration and early microglia neuroinflammation"],"prefix":"10.1016","volume":"230","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5074-9480","authenticated-orcid":false,"given":"Ekaterini","family":"Kefalakes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska J.","family":"Mewes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Peristich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Pl\u00f6tner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volodymyr","family":"Shcherbatyy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Schipke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"K\u00e4ufer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Rumpel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2025.111464_bib1","first-page":"872","article-title":"Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease","volume":"18","author":"Azeredo da Silveira","year":"2009","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.brainresbull.2025.111464_bib2","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1126\/science.133.3465.1706.b","article-title":"Excretion of dopamine in diseases of basal ganglia","volume":"133","author":"Barbeau","year":"1961","journal-title":"Science"},{"key":"10.1016\/j.brainresbull.2025.111464_bib3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","article-title":"Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction","volume":"117","author":"Beach","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainresbull.2025.111464_bib4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-0854.2008.00853.x","article-title":"Alpha-synuclein and polyunsaturated fatty acids promote clathrin-mediated endocytosis and synaptic vesicle recycling","volume":"10","author":"Ben Gedalya","year":"2009","journal-title":"Traffic"},{"key":"10.1016\/j.brainresbull.2025.111464_bib5","first-page":"39","article-title":"Chronic VIM thalamic stimulation in Parkinson's disease, essential tremor and extra-pyramidal dyskinesias","volume":"58","author":"Benabid","year":"1993","journal-title":"Acta Neurochir. Suppl. (Wien.)"},{"key":"10.1016\/j.brainresbull.2025.111464_bib6","first-page":"1","article-title":"Intracerebral grafting of neuronal cell suspensions. I. Introduction and general methods of preparation","volume":"522","author":"Bj\u00f6rklund","year":"1983","journal-title":"Acta Physiol. Scand. Suppl."},{"key":"10.1016\/j.brainresbull.2025.111464_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainresbull.2025.111464_bib8","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro","volume":"329","author":"Burr\u00e9","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.brainresbull.2025.111464_bib9","first-page":"1","article-title":"Cellular localization of brain monoamines","volume":"56","author":"Carlsson","year":"1962","journal-title":"Acta Physiol. Scand. Suppl."},{"key":"10.1016\/j.brainresbull.2025.111464_bib10","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/mt.2012.1","article-title":"Design of a single AAV vector for coexpression of TH and GCH1 to establish continuous DOPA synthesis in a rat model of Parkinson's disease","volume":"20","author":"Cederfj\u00e4ll","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.brainresbull.2025.111464_bib11","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/hmg\/ddi178","article-title":"Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection","volume":"14","author":"Chung","year":"2005","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.brainresbull.2025.111464_bib12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.brainresbull.2025.111464_bib13","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1073\/pnas.71.7.2715","article-title":"Monoamine oxidase and cerebral uptake of dopaminergic drugs","volume":"71","author":"Cotzias","year":"1974","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.brainresbull.2025.111464_bib14","first-page":"1","article-title":"Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons","volume":"232","author":"Dahlstroem","year":"1964","journal-title":"Acta Physiol. Scand. Suppl."},{"issue":"Pt 8","key":"10.1016\/j.brainresbull.2025.111464_bib15","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/brain\/122.8.1421","article-title":"The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry","volume":"122","author":"Damier","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.brainresbull.2025.111464_bib16","first-page":"S21","article-title":"Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group","volume":"54","author":"de Rijk","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.brainresbull.2025.111464_bib17","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.nbd.2011.12.013","article-title":"Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of \u03b1-synuclein in midbrain dopamine neurons","volume":"45","author":"Decressac","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainresbull.2025.111464_bib18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fnana.2014.00146","article-title":"Calbindin content and differential vulnerability of midbrain efferent dopaminergic neurons in macaques","volume":"8","author":"Dopeso-Reyes","year":"2014","journal-title":"Front Neuroanat."},{"issue":"s1","key":"10.1016\/j.brainresbull.2025.111464_bib19","first-page":"S3","article-title":"The emerging evidence of the parkinson pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.brainresbull.2025.111464_bib20","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/BF02438625","article-title":"The effect of methylene blue on monoamine oxidase and the catechol amine and 5-hydroxytryptamine metabolism of the brain","volume":"241","author":"Ehringer","year":"1961","journal-title":"Naunyn. Schmiedebergs Arch. Exp. Pathol. Pharmakol."},{"issue":"Pt 5","key":"10.1016\/j.brainresbull.2025.111464_bib21","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.brainresbull.2025.111464_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.114959","article-title":"Viral overexpression of human alpha-synuclein in mouse substantia nigra dopamine neurons results in hyperdopaminergia but no neurodegeneration","volume":"382","author":"Garcia Moreno","year":"2024","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2025.111464_bib23","doi-asserted-by":"crossref","unstructured":"GBD 2016 Parkinson's Disease Collaborators. Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 [published correction appears in Lancet Neurol. 2021 Dec;20(12):e7. Lancet Neurol. 2018;17(11):939-953. https:\/\/doi.org\/10.1016\/s1474-4422(18)30295-3.","DOI":"10.1016\/S1474-4422(21)00382-3"},{"key":"10.1016\/j.brainresbull.2025.111464_bib24","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","article-title":"The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease","volume":"51","author":"Gibb","year":"1988","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.brainresbull.2025.111464_bib25","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jnnp.54.5.388","article-title":"Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease","volume":"54","author":"Gibb","year":"1991","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.brainresbull.2025.111464_bib26","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008862","article-title":"The history of Parkinson's disease: early clinical descriptions and neurological therapies","volume":"1","author":"Goetz","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"10.1016\/j.brainresbull.2025.111464_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081426","article-title":"Morphological and behavioral impact of AAV2\/5-mediated overexpression of human wildtype alpha-synuclein in the rat nigrostriatal system","volume":"8","author":"Gombash","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.brainresbull.2025.111464_bib28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3389\/fphar.2020.00356","article-title":"Modeling Parkinson's disease with the alpha-synuclein protein","volume":"11","author":"G\u00f3mez-Benito","year":"2020","journal-title":"Front Pharm."},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111464_bib29","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1096\/fj.201701529RR","article-title":"Cre-dependent AAV vectors for highly targeted expression of disease-related proteins and neurodegeneration in the substantia nigra","volume":"32","author":"Grames","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.brainresbull.2025.111464_bib30","doi-asserted-by":"crossref","first-page":"e698","DOI":"10.1212\/WNL.0000000000200699","article-title":"Genome-wide association and meta-analysis of age at onset in parkinson disease: evidence from the COURAGE-PD consortium","volume":"99","author":"Grover","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.brainresbull.2025.111464_bib31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/mds.23455","article-title":"Glia: initiators and progressors of pathology in Parkinson's disease","volume":"26","author":"Halliday","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainresbull.2025.111464_bib32","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1006\/exnr.2002.7946","article-title":"Role of Fcgamma receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia nigra","volume":"176","author":"He","year":"2002","journal-title":"Exp. Neurol."},{"issue":"1(1","key":"10.1016\/j.brainresbull.2025.111464_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/jnc.13593","article-title":"Genetics in Parkinson disease: mendelian versus non-mendelian inheritance","volume":"139","author":"Hernandez","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2025.111464_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.brainresbull.2025.111464_bib35","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1093\/brain\/awaa238","article-title":"Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study","volume":"143","author":"Horsager","year":"2020","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111464_bib36","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.14336\/AD.2021.0517","article-title":"Adeno-associated virus expression of \u03b1-synuclein as a tool to model Parkinson\u2019s disease: current understanding and knowledge gaps","volume":"12","author":"Huntington","year":"2021","journal-title":"Aging Dis."},{"issue":"2","key":"10.1016\/j.brainresbull.2025.111464_bib37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/mds.107","article-title":"Recruitment of calbindin into nigral dopamine neurons protects against MTP-induced parkinsonism","volume":"34","author":"Inoue","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainresbull.2025.111464_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(98)00040-0","article-title":"Microglia-specific localisation of a novel calcium binding protein, Iba1","volume":"57","author":"Ito","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"3","key":"10.1016\/j.brainresbull.2025.111464_bib39","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/genes13030471","article-title":"Monogenic Parkinson's disease: genotype, phenotype, pathophysiology, and genetic testing","volume":"13","author":"Jia","year":"2022","journal-title":"Genes (Basel)"},{"issue":"11","key":"10.1016\/j.brainresbull.2025.111464_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/biom11111685","article-title":"The small molecule alpha-synuclein aggregator, FN075, enhances alpha-synuclein pathology in subclinical AAV rat models","volume":"11","author":"Kelly","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.brainresbull.2025.111464_bib41","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","article-title":"Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system","volume":"22","author":"Kirik","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2025.111464_bib42","article-title":"Analysis of skilled forelimb movement in rats: the single pellet reaching test and staircase test","volume":"58","author":"Klein","year":"2012","journal-title":"Curr. Protoc. Neurosci. Chapter 8 Unit8. 28."},{"key":"10.1016\/j.brainresbull.2025.111464_bib43","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1089\/10430340252837206","article-title":"Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra","volume":"13","author":"Klein","year":"2002","journal-title":"Hum. Gene. Ther."},{"key":"10.1016\/j.brainresbull.2025.111464_bib44","series-title":"Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects","article-title":"Animal models of Parkinson\u2019s disease","author":"Konnova","year":"2018"},{"key":"10.1016\/j.brainresbull.2025.111464_bib45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1750-1326-5-43","volume":"5","author":"Koprich","year":"2010","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.1016\/j.brainresbull.2025.111464_bib46","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat. Med"},{"key":"10.1016\/j.brainresbull.2025.111464_bib47","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/sj.gt.3301905","article-title":"Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area","volume":"10","author":"K\u00fcgler","year":"2003","journal-title":"Gene Ther."},{"issue":"2","key":"10.1016\/j.brainresbull.2025.111464_bib48","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0306-4522(96)00228-X","article-title":"Midbrain dopaminergic neuronsin the mouse co-localization with Calbindin-D28K and calretinin","volume":"75","author":"Liang","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2025.111464_bib49","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1038\/s41467-020-15626-w","article-title":"\u03b1-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease","volume":"11","author":"Lindestam Arlehamn","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.brainresbull.2025.111464_bib50","article-title":"Tissue specific expression of cre in rat tyrosine hydroxylase and dopamine active transporter-positive neurons","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.brainresbull.2025.111464_bib51","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0022-3565(25)30363-0","article-title":"The neurochemistry of Parkinson's disease: effect of L-dopa therapy","volume":"195","author":"Lloyd","year":"1975","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.brainresbull.2025.111464_bib52","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1126\/science.170.3963.1212","article-title":"Parkinson's disease: activity of L-dopa decarboxylase in discrete brain regions","volume":"170","author":"Lloyd","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.brainresbull.2025.111464_bib53","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","article-title":"Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal","volume":"8","author":"Maroteaux","year":"1988","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2025.111464_bib54","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/0140-6736(90)91006-V","article-title":"Parkinson's disease","volume":"335","author":"Marsden","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.brainresbull.2025.111464_bib55","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2174\/1566523054064995","article-title":"Adeno-associated virus (AAV) vectors in the CNS","volume":"5","author":"McCown","year":"2005","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.brainresbull.2025.111464_bib56","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0166-4328(05)80103-2","article-title":"Innate versus learned factors determining limb preference in the rat","volume":"46","author":"Miklyaeva","year":"1991","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2025.111464_bib57","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0165-0270(91)90048-5","article-title":"The \"staircase test\": a measure of independent forelimb reaching and grasping abilities in rats","volume":"36","author":"Montoya","year":"1991","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.brainresbull.2025.111464_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.113968","article-title":"Temporal, spatial and molecular pattern of dopaminergic neurodegeneration in the AAV-A53T \u03b1-synuclein rat model of Parkinson's disease","volume":"432","author":"Musacchio","year":"2022","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2025.111464_bib59","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.neuroscience.2008.01.046","article-title":"Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat","volume":"152","author":"Nair-Roberts","year":"2008","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.brainresbull.2025.111464_bib60","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3233\/JPD-212555","article-title":"Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits","volume":"12","author":"Negrini","year":"2022","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111464_bib61","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0006-8993(99)01950-2","article-title":"Calretinin and calbindin-D28k in dopaminergic neurons of the rat midbrain: a triple-labeling immunohistochemical study","volume":"846","author":"Nemoto","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2025.111464_bib62","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fnbeh.2017.00255","article-title":"Automated assessment of endpoint and kinematic features of skilled reaching in rats","volume":"11","author":"Nica","year":"2017","journal-title":"Front Behav. Neurosci."},{"key":"10.1016\/j.brainresbull.2025.111464_bib63","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3727\/096368909788341324","article-title":"Microtransplantation of dopaminergic cell suspensions: further characterization and optimization of grafting parameters","volume":"18","author":"Nikkhah","year":"2009","journal-title":"Cell Transpl."},{"key":"10.1016\/j.brainresbull.2025.111464_bib64","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0166-4328(97)00128-9","article-title":"Differences in acquisition and full performance in skilled forelimb use as measured by the 'staircase test' in five rat strains","volume":"92","author":"Nikkhah","year":"1998","journal-title":"Behav. Brain Res"},{"key":"10.1016\/j.brainresbull.2025.111464_bib65","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1750-1326-8-44","article-title":"rAAV2\/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration","volume":"8","author":"Oliveras-Salv\u00e1","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.brainresbull.2025.111464_bib66","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1523\/JNEUROSCI.15-05-03863.1995","article-title":"Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test","volume":"15","author":"Olsson","year":"1995","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.brainresbull.2025.111464_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68808-3","article-title":"Classification of \u03b1-synuclein-induced changes in the AAV \u03b1-synuclein rat model of Parkinson's disease using electrophysiological measurements of visual processing","volume":"10","author":"\u00d8stergaard","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainresbull.2025.111464_bib68","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0022-510X(79)90144-8","article-title":"Glial fibrillary acidic protein (GFAP): purification from human fibrillary astrocytoma, development and validation of a radioimmunoassay for GFAP-like immunoactivity","volume":"41","author":"Palfreyman","year":"1979","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.brainresbull.2025.111464_bib69","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","article-title":"Microglia states and nomenclature: a field at its crossroads","volume":"110","author":"Paolicelli","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.brainresbull.2025.111464_bib70","series-title":"The Rat Brain in Stereotaxic Coordinates","first-page":"1","author":"Paxinos","year":"2013"},{"key":"10.1016\/j.brainresbull.2025.111464_bib71","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1515\/JBCPP.2002.13.1.41","article-title":"Paw preference in rats","volume":"13","author":"Pen\u00e7e","year":"2002","journal-title":"J. Basic Clin. Physiol. Pharm."},{"key":"10.1016\/j.brainresbull.2025.111464_bib72","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1523\/JNEUROSCI.22-08-03090.2002","article-title":"A role for alpha-synuclein in the regulation of dopamine biosynthesis","volume":"22","author":"Perez","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2025.111464_bib73","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.brainresbull.2025.111464_bib74","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.celrep.2014.10.008","article-title":"Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling","volume":"9","author":"Poulin","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.brainresbull.2025.111464_bib75","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1017\/S0317167100041457","article-title":"Frequency and cause of Parkinson's disease","volume":"19","author":"Rajput","year":"1992","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.brainresbull.2025.111464_bib76","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3727\/096368911X586774","article-title":"The colayer method as an efficient way to genetically modify mesencephalic progenitor cells transplanted into 6-OHDA rat model of Parkinson's disease","volume":"21","author":"Ratzka","year":"2012","journal-title":"Cell Transpl."},{"key":"10.1016\/j.brainresbull.2025.111464_bib77","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1002\/cne.23051","article-title":"GIRK2 expression in dopamine neurons of the substantia nigra and ventral tegmental area","volume":"520","author":"Reyes","year":"2012","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainresbull.2025.111464_bib78","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.neuroscience.2014.11.060","article-title":"Transplantation of fetal ventral mesencephalic progenitor cells overexpressing high molecular weight fibroblast growth factor 2 isoforms in 6-hydroxydopamine lesioned rats","volume":"286","author":"Rumpel","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2025.111464_bib79","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0028-3908(00)00005-8","article-title":"CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury","volume":"39","author":"Schallert","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainresbull.2025.111464_bib80","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/00005053-196006000-00017","article-title":"Progression and prognosis in Parkinson's disease","volume":"130","author":"Schwab","year":"1960","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.brainresbull.2025.111464_bib81","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3940(03)00172-1","article-title":"Selective microglial activation in the rat rotenone model of Parkinson's disease","volume":"341","author":"Sherer","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainresbull.2025.111464_bib82","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-323-85555-6.00002-3","article-title":"Role of rodent models in advancing precision medicine for Parkinson's disease","volume":"193","author":"Simons","year":"2023","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.brainresbull.2025.111464_bib83","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/613592","article-title":"The experience of Parkinson's disease: a systematic review and meta-ethnography","volume":"2014","author":"Soundy","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.brainresbull.2025.111464_bib84","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.brainresbull.2025.111464_bib85","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.813","article-title":"Reflex-based grasping, skilled forelimb reaching, and electrodiagnostic evaluation for comprehensive analysis of functional recovery-The 7-mm rat median nerve gap repair model revisited","volume":"7","author":"St\u00f6\u00dfel","year":"2017","journal-title":"Brain Behav."},{"key":"10.1016\/j.brainresbull.2025.111464_bib86","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080952","article-title":"Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021","volume":"388","author":"Su","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.brainresbull.2025.111464_bib87","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12640-009-9053-x","article-title":"Mutant alpha-synuclein overexpression mediates early proinflammatory activity","volume":"16","author":"Su","year":"2009","journal-title":"Neurotox. Res"},{"key":"10.1016\/j.brainresbull.2025.111464_bib88","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuroscience.2016.01.003","article-title":"Aquaporin-4 mediates communication between astrocyte and microglia: implications of neuroinflammation in experimental Parkinson's disease","volume":"317","author":"Sun","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2025.111464_bib89","article-title":"Motor and nonmotor symptoms of Parkinson's disease: antagonistic pleiotropy phenomena derived from \u03b1-synuclein evolvability?","volume":"2018","author":"Takamatsu","year":"2018","journal-title":"Park. Dis."},{"key":"10.1016\/j.brainresbull.2025.111464_bib90","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.1523\/JNEUROSCI.1676-05.2005","article-title":"Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections","volume":"25","author":"Thompson","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2025.111464_bib91","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.nbd.2005.09.003","article-title":"Dopaminergic properties and function after grafting of attached neural precursor cultures","volume":"21","author":"Timmer","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainresbull.2025.111464_bib92","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1212\/WNL.50.6_Suppl_6.S2","article-title":"History of levodopa and dopamine agonists in Parkinson's disease treatment","volume":"50","author":"Tolosa","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.brainresbull.2025.111464_bib93","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.nbd.2015.06.010","article-title":"Low levels of astroglial markers in Parkinson's disease: relationship to \u03b1-synuclein accumulation","volume":"82","author":"Tong","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.brainresbull.2025.111464_bib94","first-page":"1","article-title":"Modifiable risk factors associated with the risk of developing Parkinson's disease: a critical review","volume":"83","author":"Tumas","year":"2025","journal-title":"Arq. Neuropsiquiatr."},{"issue":"8","key":"10.1016\/j.brainresbull.2025.111464_bib95","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson's disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.brainresbull.2025.111464_bib96","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0278-5846(91)90047-5","article-title":"Somatic and behavioral ontogeny in three rat strains: preliminary observations of dopamine-mediated behaviors and brain D-1 receptors","volume":"15","author":"Unis","year":"1991","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2025.111464_bib97","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/gt.2010.179","article-title":"Efficient and stable transduction of dopaminergic neurons in rat substantia nigra by rAAV 2\/1, 2\/2, 2\/5, 2\/6.2, 2\/7, 2\/8 and 2\/9","volume":"18","author":"Van der Perren","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.brainresbull.2025.111464_bib98","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0920-1211(98)00011-4","article-title":"High-frequency stimulation of the subthalamic nucleus suppresses absence seizures in the rat: comparison with neurotoxic lesions","volume":"31","author":"Vercueil","year":"1998","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.brainresbull.2025.111464_bib99","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous \u03b1-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.brainresbull.2025.111464_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-019-03013-x","article-title":"AAV2\/DJ-mediated alpha-synuclein overexpression in the rat substantia nigra as early stage model of Parkinson's disease","volume":"378","author":"von H\u00f6vel","year":"2019","journal-title":"Cell Tissue Res"},{"issue":"2","key":"10.1016\/j.brainresbull.2025.111464_bib101","first-page":"2","article-title":"Neuropathology of autonomic nervous system in Parkinson's disease","volume":"38","author":"Wakabayashi","year":"1997","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.brainresbull.2025.111464_bib102","first-page":"816","article-title":"The structure of skilled forelimb reaching in the rat: a movement rating scale","author":"Whishaw","year":"2008","journal-title":"J. Vis. Exp. 8"},{"key":"10.1016\/j.brainresbull.2025.111464_bib103","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0166-4328(97)00057-0","article-title":"Analysis of limb use by control rats and unilateral DA-depleted rats in the Montoya staircase test: movements, impairments and compensatory strategies","volume":"89","author":"Whishaw","year":"1997","journal-title":"Behav. Brain Res"},{"key":"10.1016\/j.brainresbull.2025.111464_bib104","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.brainresbull.2025.111464_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"\u03b1-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies","volume":"23","author":"Wong","year":"2017","journal-title":"Nat. Med"},{"key":"10.1016\/j.brainresbull.2025.111464_bib106","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","article-title":"Genetics and pathogenesis of Parkinson's syndrome","volume":"18","author":"Ye","year":"2023","journal-title":"Annu Rev. Pathol."},{"key":"10.1016\/j.brainresbull.2025.111464_bib107","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease","volume":"19","author":"Zhang","year":"2005","journal-title":"Faseb J."},{"key":"10.1016\/j.brainresbull.2025.111464_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105094","article-title":"Activated microglia facilitate the transmission of \u03b1-synuclein in Parkinson's disease","volume":"148","author":"Zheng","year":"2021","journal-title":"Neurochem. Int."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036192302500276X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036192302500276X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:29:11Z","timestamp":1780028951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036192302500276X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":108,"alternative-id":["S036192302500276X"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2025.111464","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A holistic rat model to investigate therapeutic interventions in Parkinson\u2019s disease: viral induction of a slow-progressing motor phenotype, dopaminergic degeneration and early microglia neuroinflammation","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2025.111464","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111464"}}